Merrimack Pharmaceuticals
MACK
$14.98
Share price
1.63%
Change (1 day)
18.98%
Change (1 year)
Categories
Merrimack Pharmaceuticals (MACK) Fails to deliver data
Key failure to deliver metrics for Merrimack Pharmaceuticals:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.07 M
- Last 3 months FTD volume: $0.18 M
- Last year FTD volume: $0.93 M
Failures to deliver for Merrimack Pharmaceuticals (MACK) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Merrimack Pharmaceuticals (MACK) - since 2017
Volume in USD (price x number of shares), data since 2017Merrimack Pharmaceuticals (MACK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.18 M | -86.64% |
| 2023 | $1.4 M | -34.2% |
| 2022 | $2.13 M | 526.94% |
| 2021 | $0.34 M | -61.29% |
| 2020 | $0.88 M | 517.07% |
| 2019 | $0.14 M | -90.31% |
| 2018 | $1.47 M | -75.68% |
| 2017 | $6.06 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sanofi SNY | $26.39 M | $50.57 M | 🇫🇷 France |
 Geron GERN | $10.86 M | $15.05 M | 🇺🇸 USA |
 Clovis Oncology CLVS | $7.84 M | $96.73 M | 🇺🇸 USA |
 AVEO Oncology
AVEO | N/A | $0.04 M | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.04 M | $0.25 M | 🇺🇸 USA |